NVISION Eye Centers' Subsidiary, NVISION Clinical Research, Rapidly Expands Under New Leadership
04 Mar 2024
Executive Change
ALISO VIEJO, Calif.--(BUSINESS WIRE)--NVISION Eye Centers, a renowned national leader in comprehensive eye care services, proudly announces the remarkable expansion of its subsidiary, NVISION Clinical Research, LLC. Spearheaded by the visionary leadership of its President and GM, Michael Gibertini, PhD, who assumed the role in August 2023, NVISION Clinical Research has swiftly expanded both its range of trials as well as the number of key investigators to lead this innovation.
'We are delighted to welcome Dr. Gibertini to our team of dedicated professionals who embody our Patient First ethos'
NVISION Clinical Research, LLC, an integral member of the NVISION family, is exclusively dedicated to facilitating clinical trial opportunities to patients treated by NVISION ophthalmologists. With more than 40 physician investigators across 20 clinical trial sites, NVISION Clinical Research, LLC operates one of the largest ophthalmology-specialized clinical trial site networks nationwide. The company remains committed to adding new investigators from NVISION’S expanding platform of more than 100 practice partners throughout the USA.
“We are delighted to welcome Dr. Gibertini to our team of dedicated professionals who embody our Patient First ethos," expressed Chris Karkenny, CEO of NVISION. “In just a few short months, Dr. Gibertini has orchestrated the creation and implementation of an integrated, scalable platform for clinical research within NVISION, fostering new opportunities for professional growth for our physician partners, enhancing patient access and rapid study-startup for our trial partners, and reinforcing our unwavering commitment to clinical care excellence for our patients,” said Chris Karkenny, CEO of NVISION.
Dr. Gibertini brings a wealth of experience to his role, having previously served as Chief Development Officer at Elligo Health Research and President of Clinical Development at Syneos Health. With over 30 years of expertise in pharmaceutical drug and device development, he is a recognized authority in clinical trial methodology and operations. As a seasoned executive in the clinical research arena, Dr. Gibertini is ideally positioned to steer NVISION Clinical Research, LLC through its next phase of growth.
"I am thrilled by the rapid progress we have made in implementing our new ophthalmology research support model within the first few months," remarked Dr. Gibertini. "We have successfully enlisted new clinical investigators across Oregon, Utah, Arizona, Texas, and expanded our presence within California. Our mission is clear: to provide unwavering support to each and every NVISION ophthalmology practice in their pursuit of clinical trials."
About NVISION Eye Centers
NVISION Eye Centers is comprised of over 100 locations and ambulatory surgery centers strategically positioned as partnerships and joint ventures in California, Arizona, Nevada, Oregon, Utah and Texas. NVISION’s resolute commitment to quality, exemplified by its accomplished surgeons and dedicated staff, places Patients First, resulting in consistently outstanding outcomes. NVISION is uniquely positioned for continued growth and success in the changing landscape of vision care. For more information, please visit www.nvisioncenters.com.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.